Genetic Technologies Limited
GTG.AX
Australian Securities Exchange0.04
AUD
- -
- -
Total Valuation
Genetic Technologies Limited carries a market capitalization of 5.67M, placing it among publicly traded companies globally.
| Market Cap | 5.67M |
| Enterprise Value | N/A |
Financial Position
Genetic Technologies Limited maintains a current ratio of 2.55, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.55 |
| Quick Ratio | 2.17 |
| Debt / Equity | 55.76 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Stock Price Statistics
Genetic Technologies Limited's stock has declined approximately -80.5% over the past 52 weeks. The 50-day moving average sits at 0.04, while the 200-day moving average is 0.06.
| Beta (5Y) | N/A |
| 52-Week Price Change | -80.5% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.06 |
| Average Volume (20 Days) | N/A |
Cash Flow
| Operating Cash Flow | N/A |
| Capital Expenditures | -18,967.00 |
| Free Cash Flow | -18,967.00 |
| FCF Per Share | N/A |
Stock Splits
Genetic Technologies Limited's most recent stock split took place on August 7, 2024 with a 43:45 split ratio.
| Last Split Date | 8/7/2024 |
| Split Ratio | 43:45 |
Scores
Genetic Technologies Limited posts an Altman Z-Score of -93.38, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -93.38 |